Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Mar;168(3):291-299.
doi: 10.1177/01945998221113310. Epub 2023 Jan 29.

Improving Pneumococcal Vaccination Rates in Cochlear Implant Programs: A Systematic Review and Meta-analysis

Annie F Britt  1 , Nicolas S Poupore  2   3 , Shaun A Nguyen  2 , David R White  2
Affiliations
Meta-Analysis

Improving Pneumococcal Vaccination Rates in Cochlear Implant Programs: A Systematic Review and Meta-analysis

Annie F Britt et al. Otolaryngol Head Neck Surg. 2023 Mar.

Abstract

Objective: To review the literature on pneumococcal vaccination compliance rates among cochlear implant (CI) patients and to examine the utility of intervention programs on increasing vaccination rates.

Data sources: PubMed, Scopus, and CINAHL.

Review methods: A systematic review was performed following PRISMA guidelines. Studies of pneumococcal vaccination rates at baseline and before and after the implementation of a quality improvement (QI) intervention were included. A total of 641 studies were screened, and 13 studies met inclusion criteria. Meta-analyses of pneumococcal vaccination rates pre- and post-QI intervention in CI patients were performed.

Results: A total of 12,973 children and adults were included. The baseline PCV13 and PPSV23 vaccination rates were 53.45% (95% CI, 37.02%-69.51%) and 42.53% (95% CI, 31.94%-53.48%), respectively. Comparing children and adults, PCV13 and PPSV23 baseline vaccination rates were not statistically significant. The PPSV23 vaccine rate after QI initiatives was significantly higher than the baseline rate at 83.52% (95% CI, 57.36%-98.46%). After these interventions, patients had a 15.71 (95% CI, 4.32-57.20, P < .001) increased odds of receiving PPSV23 vaccination compared to before QI implementation.

Conclusions: The baseline rates of PCV13 and PPSV23 are highly variable and lower than expected, given current vaccination recommendations for CI patients. QI programs appear successful in increasing compliance rates with the PPSV23 vaccination; however, they are still far from full compliance. Further intervention programs with stricter surveillance, monitoring, and follow-up systems are needed to achieve improved compliance with the PCV13 and PPSV23 vaccination in CI recipients.

Keywords: cochlear implant; pneumococcal meningitis; systematic review; vaccination.

PubMed Disclaimer

References

    1. Deep NL, Dowling EM, Jethanamest D, Carlson ML. Cochlear implantation: an overview. J Neurol Surg B Skull Base. 2019;80(2):169-177.
    1. Carlyon RP, Goehring T. Cochlear implant research and development in the twenty-first century: a critical update. J Assoc Res Otolaryngol. 2021;22(5):481-508.
    1. Binnetoglu A, Demir B, Batman C. Surgical complications of cochlear implantation: a 25-year retrospective analysis of cases in a tertiary academic center. Eur Arch Otorhinolaryngol. 2020;277(7):1917-1923.
    1. Wei BP, Robins-Browne RM, Shepherd RK, Clark GM, O'Leary SJ. Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis. 2008;46(1):e1-7.
    1. Terry B, Kelt RE, Jeyakumar A. Delayed complications after cochlear implantation. JAMA Otolaryngol Head Neck Surg. 2015;141(11):1012-1017.

LinkOut - more resources